Alsawalha Murad, Al-Subaie Abeer Mohammed, Al-Jindan Reem Yousuf, Bolla Srinivasa Rao, Balakrishna Janardhana Papayya, Ravi Padma Kanchi, Gollapalli Shiva Shankar Reddy, Veeraraghavan Vishnu Priya, Pillai Aruthra Arumugam, Joseph Joel Palpath, Mohan Surapaneni Krishna
Department of Chemical and Process Engineering Technology, Jubail Industrial College (JIC), P.O.Box 10099, Jubail Industrial City 31961, Kingdom of Saudi Arabia.
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, P.O.Box 2435, Dammam 31441, Kingdom of Saudi Arabia.
J Pharm Bioallied Sci. 2019 Jul-Sep;11(3):240-247. doi: 10.4103/jpbs.JPBS_53_19.
Numerous synthetic drugs have been recommended as a remedy for diabetes, but their role in hypoglycemic effects are diverse. The side effects associated with these drugs due to their extended use led scientists to find unconventional medicines with no or little side effects.
This study was aimed at assessment of antidiabetic activities of methanolic extract of leaves by using 3T3L1 cell line.
The cytotoxic effect of the leaf extract was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The glucose uptake-inducing capabilities and its correlation with glucose transporter 4 (GLUT4) translocation were measured by flow cytometry in 3T3L1 cells. In addition, the inhibitory effect of leaf extract on α-amylase activity and α-glucosidase activity was determined by colorimetric methods.
Different concentrations of leaf extract did not show any toxicity on 3T3L1 cells, after the treatment for 24h. On stimulation with leaf extract, 60.22% and 86.26% of 3T3L1 cells showed glucose uptake and GLUT4 expression, respectively. The colorimetric assays showed that the methanolic leaf extract of has a significant inhibitory effect on the activity of α-amylase enzyme and α-glucosidase enzyme with inhibitory concentration (IC) value of 248.65 µg/mL and 229.61 µg/mL, respectively.
On the basis of the results of this study, it is evident that leaf extract showed promising anti-diabetic effect when compared to the standard drugs metformin and acarbose and was nontoxic to 3T3L1 cells. Thus, it can be further investigated to recommend as a possible alternative treatment in antidiabetic applications.
众多合成药物已被推荐用于治疗糖尿病,但其降血糖作用各异。由于这些药物长期使用会产生副作用,促使科学家寻找副作用小或无副作用的非传统药物。
本研究旨在利用3T3L1细胞系评估叶甲醇提取物的抗糖尿病活性。
通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)法测定叶提取物的细胞毒性作用。采用流式细胞术检测3T3L1细胞中葡萄糖摄取诱导能力及其与葡萄糖转运蛋白4(GLUT4)转位的相关性。此外,通过比色法测定叶提取物对α-淀粉酶活性和α-葡萄糖苷酶活性的抑制作用。
不同浓度的叶提取物处理3T3L1细胞24小时后,未显示出任何毒性。用叶提取物刺激后,分别有60.22%和86.26%的3T3L1细胞表现出葡萄糖摄取和GLUT4表达。比色法检测表明,叶甲醇提取物对α-淀粉酶和α-葡萄糖苷酶活性具有显著抑制作用,抑制浓度(IC)值分别为248.65 µg/mL和229.61 µg/mL。
基于本研究结果,显然叶提取物与标准药物二甲双胍和阿卡波糖相比,具有良好的抗糖尿病作用,且对3T3L1细胞无毒。因此,可进一步研究将其推荐为抗糖尿病应用中的一种可能替代治疗方法。